TABLE 1.
Extracellular solutions (mM) | NaCl | NaMs | KCl | KMs | NMDG-Cl | NMDG-Ms | MgCl2 | MgMs2 | K2EGTA | Na2EGTA | NaH2PO4 | HEPES |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Ca-free Tyrode's | 135 | 0 | 5.4 | 0 | 0 | 0 | 1.0 | 0 | 0.1 | 0 | 0.33 | 10 |
Mg-loading | 0 | 0 | 5.4 | 0 | 101 | 0 | 17.9 | 6.0 | 0.1 | 0 | 0.33 | 10 |
75 K-70 Na | 3.5 | 66.2 | 5.4 | 65.3 | 0 | 0 | 1.0 | 0 | 0.1 | 0 | 0.33 | 10 |
0 K-70 Na | 69.5 | 0 | 0 | 0 | 70.3 | 0 | 1.0 | 0 | 0 | 0.1 | 0.33 | 10 |
0 K-70 Na-0 Cl | 0 | 69.5 | 0 | 0 | 0 | 70.3 | 0 | 1.0 | 0 | 0.1 | 0.33 | 10 |
0 K-0.5 Na | 0 | 0 | 0 | 0 | 135 | 0 | 1.0 | 0 | 0 | 0.1 | 0.33 | 10 |
0 K-0.5 Na-0 Cl | 0 | 0 | 0 | 0 | 0 | 135 | 0 | 1.0 | 0 | 0.1 | 0.33 | 10 |
Pipette solutions (mM) | KMs | CsMs | NaCl | CsCl | CaCl2 | CaMs2 | MgCl2 | MgMs2 | MOPS | [K+] | [Na+] | [Cl−] |
135 K-10 Na | 130 | 0 | 10 | 0 | 1.0 | 0 | 1.0 | 0 | 10 | 135 | 10 | 14 |
145 Cs | 0 | 130 | 0 | 10 | 1.0 | 0 | 1.0 | 0 | 10 | 0 | 0 | 14 |
145 Cs-0 Cl | 0 | 140 | 0 | 0 | 0 | 1.0 | 0 | 1.0 | 10 | 0 | 0 | 0 |
Ms, methanesulfonate; NMDG-Cl, N-methyl-D-glucamine titrated by HCl; NMDG-Ms, N-methyl-D-glucamine titrated by methanesulfonic acid. Extracellular solutions also contained 5 mM glucose in common. The pH of the extracellular solutions was adjusted to 7.40 by adding NaOH (Ca-free Tyrode's), NaOH plus HCl (Mg-loading), KOH (75 K-70 Na), HCl (0 K-70 Na and 0 K-0.5 Na) or HMs (0 K-70 Na-0 Cl and 0 K-0.5 Na-0 Cl). Final Na+ concentrations were 140 mM (Ca-free Tyrode's), 1.6 mM (Mg-loading), 70 mM (75 K-70 Na, 0 K-70 Na, and 0 K-70 Na-0 Cl) and 0.5 mM (0 K-0.5 Na and 0 K-0.5 Na-0 Cl). The pH of the pipette solutions was adjusted to 7.15 with either 5 mM KOH (135 K-10 Na) or 5 mM CsOH (145 Cs and 145 Cs-0 Cl). The three rightmost columns under Pipette solutions give the final concentrations of K+, Na+, and Cl−.